Investigational Drug Information for Ceralasertib
✉ Email this page to a colleague
What is the development status for investigational drug Ceralasertib?
Ceralasertib is an investigational drug.
There have been 20 clinical trials for Ceralasertib.
The most recent clinical trial was a Phase 1 trial, which was initiated on September 15th 2022.
The most common disease conditions in clinical trials are Neoplasms, Lung Neoplasms, and Breast Neoplasms. The leading clinical trial sponsors are AstraZeneca, National Cancer Institute (NCI), and Parexel.
There are five US patents protecting this investigational drug and forty-two international patents.
Summary for Ceralasertib
US Patents | 5 |
International Patents | 42 |
US Patent Applications | 50 |
WIPO Patent Applications | 38 |
Japanese Patent Applications | 4 |
Clinical Trial Progress | Phase 1 (2022-09-15) |
Vendors | 49 |
Recent Clinical Trials for Ceralasertib
Title | Sponsor | Phase |
---|---|---|
Ceralasertib Followed by Durvalumab and Nab-paclitaxel Combination in mTNBC Patients | AstraZeneca | Phase 2 |
Ceralasertib Followed by Durvalumab and Nab-paclitaxel Combination in mTNBC Patients | IFOM, The FIRC Institute of Molecular Oncology | Phase 2 |
A Study to Evaluate the Safety and Pharmacokinetics of Ceralasertib in Combination With Durvalumab in Chinese Patients With Advanced Solid Tumours | AstraZeneca | Phase 1 |
Clinical Trial Summary for Ceralasertib
Top disease conditions for Ceralasertib
Top clinical trial sponsors for Ceralasertib
US Patents for Ceralasertib
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
Ceralasertib | ⤷ Try a Trial | Chemical compounds | Astrazeneca AB (Sodertalje, SE) | ⤷ Try a Trial |
Ceralasertib | ⤷ Try a Trial | Chemical compounds | AstraZeneca AB (Sodertalje, SE) | ⤷ Try a Trial |
Ceralasertib | ⤷ Try a Trial | Chemical compounds | AstraZeneca AB (Sodertalje, SE) | ⤷ Try a Trial |
Ceralasertib | ⤷ Try a Trial | Chemical compounds | AstraZeneca AB (Sodertalje, SE) | ⤷ Try a Trial |
Ceralasertib | ⤷ Try a Trial | Chemical compounds | AstraZeneca AB (Sodertalje, SE) | ⤷ Try a Trial |
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Ceralasertib
Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
---|---|---|---|---|
Ceralasertib | Argentina | AR081859 | 2030-06-11 | ⤷ Try a Trial |
Ceralasertib | Australia | AU2011263491 | 2030-06-11 | ⤷ Try a Trial |
Ceralasertib | Brazil | BR112012031561 | 2030-06-11 | ⤷ Try a Trial |
Ceralasertib | Canada | CA2800203 | 2030-06-11 | ⤷ Try a Trial |
Ceralasertib | Chile | CL2012003503 | 2030-06-11 | ⤷ Try a Trial |
Ceralasertib | China | CN103068391 | 2030-06-11 | ⤷ Try a Trial |
>Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |